-
-
-
-
-
-
-
Syndax presents real-world data for menin inhibitor at ASH conference
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) halted, news pending
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) PT Raised to $51 at Citi, Opens 90d Catalyst Watch
-
-
-
-
-
-
-
Goldman Sachs Starts Syndax Pharmaceuticals (SNDX) at Buy
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 26c
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman Sachs
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

